Ken Griffin Bioventus Inc. Call Options Transaction History

Citadel Advisors LLC

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2024 Nov 14, 2024	BUY	$5.73 - $11.95 $48,705 - $101,575	8,500 Added 125.0%	15,300 $182,000
Q2 2024 Aug 14, 2024	BUY	$3.96 - $6.93 $1,584 - $2,772	400 Added 6.25%	6,800 $39,000
Q1 2024 May 15, 2024	SELL	$4.33 - $5.75 $21,217 - $28,175	-4,900 Reduced 43.36%	6,400 $33,000
Q4 2023 Feb 14, 2024	BUY	$2.89 - $5.34 $13,872 - $25,632	4,800 Added 73.85%	11,300 $59,000
Q3 2023 Nov 14, 2023	SELL	$2.8 - $4.94 $2,240 - $3,952	-800 Reduced 10.96%	6,500 $21,000
Q2 2023 Aug 14, 2023	BUY	$0.93 - $3.64 $6,789 - $26,572	7,300 New	7,300 $21,000
Q4 2022 Feb 14, 2023	BUY	$1.81 - $8.14 $8,326 - $37,444	4,600 New	4,600 $12,000

142

45.9M

179K

124K

Ticker BVS
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 61,664,200
Market Cap $704M
Description
Bioventus Inc. a medical device company, focuses on developing and commercializing clinical treatments that engage and enhance the body's natural healing process in the United States and internationally. The company's product portfolio includes pain treatments, which comprise non-surgical joint pain injection therapies, as well as peripheral ner...

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.